Soligenix inc (SNGX) - News Archive

Showing 2 of 2 results.

Soligenix Secures Exciting Results for HyBryte in CTCL Study, Boosting Valuation to $35

Soligenix Inc. (NASDAQ:SNGX) recently unveiled positive interim results from an investigator-initiated study involving HyBryte, a potential treatment for Cutaneous T-Cell Lymphoma (CTCL). The encouraging findings have p...

Jul 16, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Investigator Alcoa Corporation Soligenix Soligenix

Soligenix Inc A Promising Outlook and Positive Study Results Propelling Growth in the Pharmaceutical Industry

In the dynamic landscape of the pharmaceutical industry, Soligenix Inc (NASDAQ: SNGX) has emerged as a prominent player, garnering attention from industry analysts and investors alike. This article explores recent devel...

Jun 28, 2024 • Major Pharmaceutical Preparations Industry Stocks on the Move Soligenix Inc Composite Assessment Carisma Soligen